Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: DAN LITTLE who wrote (352)	6/11/1998 12:21:00 PM
From: OLD JAKE JUSTUS	Read Replies (1) \| Respond to of 4891

My good friend, Dan Little! I know that you are a busy man. But, do you recall ever hearing anything mentioned about Mexico City tests going on? I did not see it mentioned in the SEC filings. What is going on down there, do you know? I noticed in the Reuters ADVR report that Dr. Hirschman thinks he will have the answers about Reticulose, from the Argentina tests and the Mexico City test, to apply for an NDA from the FDA. Does this mean, as you have often theorized, that they have, or they are to receive soon an IND from the US FDA? It certainly looks that way to me. Only Reticulose side effects reported from previous tests: Soreness where injected. Burning sensation when injected. WOW! This is great news!